-The Economic Times The crisis of the euro, a current account deficit of over 4%, double-digit inflation, corruption in governance and a failing political system. It would not be unfair to say that these factors have combined in varying degrees at different times to lead to the conclusion that the globally-acclaimed India growth story seems to be heading for an unhappy ending. Many have labelled this - unfairly, I think - as...

John Vidal, who was in Rio for the '92 Earth summit, looks back at that momentous event, and how the 2012 version compares Helicopters thundered up and down the chic Copacabana and Ipanema beaches. Tanks guarded the bridges and tunnels. The favelas were in lockdown, schools closed and supermarkets stood empty. Unexpectedly, George H W Bush, the 41st US president, flush with success at the collapse of communism, had arrived in...

Joseph Munyi, a Kenyan citizen, has been living with HIV for 8 years and, much like other HIV patients, is unemployed. He has been receiving his medication free of charge on account of government programmes and outreach programmes of Medicine Sans Frontieres. His medication comes in the form of generic drugs. However, this situation may not last long as economic interests of few may end up impeding many a public spirited...

-PTI Jan Myrdal, son of the celebrated Nobel laureate couple--Gunnar and Alva Myrdal--is banned from visiting India because the government believes he is a Maoist supporter. The government of India is contemplating a ban on the future visits of 85-year-old Jan Myrdal, whose parents were close friends of former Prime Ministers Jawaharlal Nehru and Indira Gandhi, for his alleged backing of pro-Maoist ideology. The home ministry has found that the Sweden-based author had attended...

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...